Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-04-30
1991-02-19
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
424489, 264109, 264114, 264117, A61K 31525, A61K 916
Patent
active
049944584
ABSTRACT:
A riboflavin granulate containing from 75 to 99.5 weight percent riboflavin is produced by:
REFERENCES:
patent: 3959472 (1976-05-01), Cawnalonga et al.
patent: 4486435 (1984-12-01), Schmidt et al.
patent: 4540602 (1985-09-01), Motoyama et al.
patent: 4563315 (1986-01-01), Walter
patent: 4643898 (1987-02-01), Peters et al.
patent: 4721716 (1988-01-01), Neesby
patent: 4725427 (1988-02-01), Ashmead et al.
patent: 4840799 (1989-06-01), Appelgren et al.
patent: 4868180 (1989-09-01), Izuhara et al.
Jager et al., Pharm. Ind., 44(2):193-196 (1982), Effect of Material Motion on Agglomeration in the Rotary Fluidized-Bed Granulator.
Olsen, Plant/Operations Progress, 4(3):135-138, Jul. 1985, "Recent Advances in Fluid Bed Agglomeration and Coating Technology".
BASF Corporation
Chipaloski Michael R.
Hurley Rupert B.
Rose Shep K.
LandOfFree
Process for rotary fluid bed granulation of riboflavin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for rotary fluid bed granulation of riboflavin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for rotary fluid bed granulation of riboflavin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1143817